Bioventus Inc. — Director's Dealing 2023

Jun 9, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bioventus Inc. (BVS)
CIK: 0001665988
Period of Report: 2023-06-06

Reporting Person: STALNECKER SUSAN M (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-06	Class A Common Stock	M	16648	—	Acquired	49064	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-06	Restricted Stock Units	$	M	16648	Disposed		Class A Common Stock (16648)	Direct
2023-06-07	Restricted Stock Units	$	A	30400	Acquired		Class A Common Stock (30400)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.

F2: The RSUs vested on June 6, 2023.

F3: The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.